Mateu-Salat Manel, Stanton-Yonge Nicole, Santaló Frederic Sampedro, Vela José Ignacio, Cascajosa Jesús Díaz, Pérez Eva Safont, Rego-Lorca Daniela, Chico Ana
Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain.
Endocrinology and Nutrition Unit, Hospital General de Granollers, Granollers, Spain.
Endocrinol Diabetes Metab. 2025 Jan;8(1):e70018. doi: 10.1002/edm2.70018.
Retinal microperimetry (MPR) is a non-invasive method that measures retinal light sensitivity (RS) and gaze fixation stability (GFS). MPR has been described as a marker of cognitive impairment in people with Type 2 diabetes, but it has never been assessed in people with Type 1 diabetes (T1D). Our group described subclinical cognitive alterations, structural brain differences, and increased levels of light chain neurofilament (NfL) in people with T1D and impaired awareness of hypoglycaemia.
To measure RS and GFS using MPR in individuals with T1D and evaluate its correlation with neuropsychological assessment, plasma NfL levels and CGM-derived glucometric parameters.
to evaluate the possible differences of RS and GFS in people with T1D depending on hypoglycaemia awareness.
DESIGN, SETTING AND PARTICIPANTS: Pilot observational study, people with T1D without clinical cognitive impairment, moderate-severe retinopathy or glaucoma. MPR was performed with MAIA3.
A total of 30 subjects were studied: 40% women, age 58 ± 11 years; T1D duration 31 ± 9 years, mild retinopathy 33%. RS was 27.5 dB (26.1-28.3) and GFS(%) 97.6% (93.5%-99.5%). We found a correlation between RS and memory alteration tests (p = 0.016) and between GFS(%) and a composite of attention and executive neuropsychological tests (p = 0.025). An inverse correlation between GFS and time below range was found. No correlation was found with NfL.
This first exploratory study in people with T1D supports the potential utility of MPR as a screening tool for subclinical neurocognitive alterations in this population.
视网膜微视野计(MPR)是一种测量视网膜光敏感度(RS)和注视稳定性(GFS)的非侵入性方法。MPR已被描述为2型糖尿病患者认知障碍的一个标志物,但从未在1型糖尿病(T1D)患者中进行过评估。我们团队描述了T1D患者以及低血糖意识受损患者存在亚临床认知改变、脑结构差异和轻链神经丝(NfL)水平升高。
使用MPR测量T1D个体的RS和GFS,并评估其与神经心理学评估、血浆NfL水平和连续血糖监测(CGM)得出的血糖参数的相关性。
评估T1D患者中RS和GFS根据低血糖意识的可能差异。
设计、地点和参与者:试点观察性研究,纳入无临床认知障碍、中度至重度视网膜病变或青光眼的T1D患者。使用MAIA3进行MPR检查。
共研究了30名受试者:40%为女性,年龄58±11岁;T1D病程31±9年,轻度视网膜病变占33%。RS为27.5 dB(26.1 - 28.3),GFS(%)为97.6%(93.5% - 99.5%)。我们发现RS与记忆改变测试之间存在相关性(p = 0.016),GFS(%)与注意力和执行神经心理学测试的综合指标之间存在相关性(p = 0.025)。发现GFS与低于范围时间之间存在负相关。未发现与NfL存在相关性。
这项针对T1D患者的首次探索性研究支持MPR作为该人群亚临床神经认知改变筛查工具的潜在效用。